Tumor Organoids

Front Cover
Shay Soker, Aleksander Skardal
Humana Press, Oct 20, 2017 - Medical - 213 pages

Cancer cell biology research in general, and anti-cancer drug development specifically, still relies on standard cell culture techniques that place the cells in an unnatural environment. As a consequence, growing tumor cells in plastic dishes places a selective pressure that substantially alters their original molecular and phenotypic properties.The emerging field of regenerative medicine has developed bioengineered tissue platforms that can better mimic the structure and cellular heterogeneity of in vivo tissue, and are suitable for tumor bioengineering research. Microengineering technologies have resulted in advanced methods for creating and culturing 3-D human tissue. By encapsulating the respective cell type or combining several cell types to form tissues, these model organs can be viable for longer periods of time and are cultured to develop functional properties similar to native tissues. This approach recapitulates the dynamic role of cell–cell, cell–ECM, and mechanical interactions inside the tumor. Further incorporation of cells representative of the tumor stroma, such as endothelial cells (EC) and tumor fibroblasts, can mimic the in vivo tumor microenvironment. Collectively, bioengineered tumors create an important resource for the in vitro study of tumor growth in 3D including tumor biomechanics and the effects of anti-cancer drugs on 3D tumor tissue. These technologies have the potential to overcome current limitations to genetic and histological tumor classification and development of personalized therapies.



Techniques to Produce and Culture Lung Tumor Organoids
Mammary Gland Organoids
Biofabrication Technologies for Developing In Vitro Tumor Models
Three Dimensional In Vitro Tumor Platforms for Cancer Discovery
TissueEngineered Models for Studies of Bone Metastasis
Organoid Systems to Investigate Angiogenesis
Microfluidics in Cell and Tissue Studies
StiffnessTuned Matrices for Tumor Cell Studies
Toward Personalized Medicine

Other editions - View all

Common terms and phrases

About the author (2017)

Shay Soker, PhD, is Professor, Regenerative Medicine, Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine.
Aleksander Skardal, PhD, is Assistant Professor, Regenerative Medicine and Biomedical Engineering, Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine.

Bibliographic information